Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

131
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
131
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

84
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
84
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

97
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
97
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

121
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
121
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

69
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
69
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

66
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review of Type 1 Diabetes.

JAMA·2026
Same authorSame journal

Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management.

Obstetrical & gynecological survey·2026
Same authorSame journal

Female Sexual Dysfunction: Current Models and Treatment Options.

Obstetrical & gynecological survey·2026
Same author

Birth Trauma and Postpartum Childbirth-related Posttraumatic Stress Disorder: A Narrative Review of Pathology, Risk Factors, and Practice Recommendations.

Obstetrical & gynecological survey·2026
Same author

Penicillin Allergy in Pregnancy: A Practical Review for the Obstetrician.

Obstetrical & gynecological survey·2026
Same author

#GroupBStrepTest on TikTok: What Social Media Reveals About Patient Experiences and Expectations.

Journal of midwifery & women's health·2026
Same journal

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.

Obstetrical & gynecological survey·2026
Same journal

A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

Obstetrical & gynecological survey·2026
Same journal

Heavy Menstrual Bleeding in the Gynecology Clinic: A Call for Awareness and Standardized Screening for Underlying Bleeding Disorders.

Obstetrical & gynecological survey·2026
Same journal

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
See all related articles

Related Experiment Video

Updated: Oct 22, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.7K

Peripartum Cardiomyopathy.

Amanda S Farrell1, Jeffrey A Kuller2, Sarah A Goldstein3

  • 1Medical Student.

Obstetrical & Gynecological Survey
|August 27, 2021
PubMed
Summary
This summary is machine-generated.

Peripartum cardiomyopathy is a rare heart failure affecting pregnant and postpartum women. Early diagnosis and multidisciplinary management are crucial for improving patient outcomes.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.0K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

986

Related Experiment Videos

Last Updated: Oct 22, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.7K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.0K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

986

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare left ventricular systolic dysfunction occurring late in pregnancy or postpartum.
  • Diagnosis is challenging due to overlapping symptoms with normal pregnancy physiology, necessitating a high index of suspicion.

Purpose of the Study:

  • To review current understanding of peripartum cardiomyopathy.
  • To highlight diagnostic challenges, risk factors, and management strategies.

Main Methods:

  • A review of original research articles, review articles, and clinical guidelines on PPCM was conducted.

Main Results:

  • Etiology is unclear, with theories including genetic predisposition, inflammation, and angiogenic dysregulation.
  • Risk factors include hypertensive disorders, Black race, and maternal age over 30.
  • Patients face risks of decompensation, arrhythmias, thromboembolism, and death.
  • Treatment focuses on optimizing preload and afterload with medications; delivery timing depends on maternal status.

Conclusions:

  • Prompt diagnosis and interdisciplinary medical management are vital for improving outcomes in PPCM patients.